Home » Topics » Regulatory

Regulatory
RSS

Hyal's treatment for sun spots approved in the U.K.

July 3, 1997

FDA approves Mirapex for the treatment of Parkinson's disease

July 3, 1997

Rebamipide for diabetic nephropathy

July 3, 1997

Topical t-PA for the treatment of venous ulcers

July 2, 1997

TIMI-IIA finds enoxaparin promising

July 1, 1997

Epilepsy monotherapy approved in Canada

July 1, 1997

New indication for enoxaparin recommended for approval

June 27, 1997

Advisory committee recommends Taxol for KS

June 27, 1997

RTP Pharma receives U.S. patent for new formulation of propofol

June 25, 1997

Minocycline superior to placebo for early RA

June 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...